Sydnexis
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $45M
Investors
- 6
About Sydnexis
Based in California, US, and founded in 2014, Sydnexis, Inc. operates as a clinical-stage biopharmaceutical company. In April 2024, Sydnexis, Inc.1 million post-money. Sternberg. Sydnexis develops treatments for childhood myopia, also known as nearsightedness. The firm’s pipeline product includes SYD-101, which is an investigational low-dose atropine sulfate ophthalmic solution to slow down the progression of myopia in children.
Who invested in Sydnexis
6 investors across 1 round
See all investors in Sydnexis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 10, 2021
Amount
$45M
Investors
Questions about Sydnexis
Who invested in Sydnexis?
Sydnexis has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sydnexis raised?
Sydnexis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sydnexis last raise money?
Sydnexis's most recent round on record is a Series B, in Jul 2021.
What does Sydnexis do?
Based in California, US, and founded in 2014, Sydnexis, Inc.
Where is Sydnexis headquartered?
Sydnexis is headquartered in Del Mar, US.
Which VCs invest in companies like Sydnexis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sydnexis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sydnexis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.